lexaria glp 1 liraglutide #glp1 #obesity Lexaria's Patented Technology Improved the

GSH (reduced glutathione) inhalation is an effective treatment for a variety of pulmonary diseases and respiratory-related conditions

Dietary modifications: Eat smaller, more frequent meals rather than large portions, which can exacerbate nausea Choose bland, easily digestible foods during the initial weeks (toast, crackers, rice, bananas) Avoid high-fat, spicy, or heavily seasoned foods that may worsen gastrointestinal symptoms Stay well-hydrated with small, frequent sips of water throughout the day Avoid lying down immediately after eating remain upright for at least 30-60 minutes Medication timing and administration: Take injections at a consistent time each day/week according to your prescription Consider timing administration based on your personal preference and when symptoms are most manageable for you Ensure proper injection technique and rotate injection sites to minimise local reactions Follow the prescribed dose escalation schedule never increase doses faster than recommended Symptomatic relief measures: Ginger tea or ginger supplements may help reduce nausea (consult your pharmacist regarding appropriate products) Anti-emetic medications may be prescribed by your GP for persistent nausea: Metoclopramide should only be used short-term (maximum 5 days) due to risk of neurological side effects Prochlorperazine may cause drowsiness and dizziness when standing up Ondansetron may be considered for more persistent symptoms Adequate rest and avoiding overexertion during the adjustment period Cool compresses for headaches, alongside paracetamol if needed (following standard dosing guidelines) Avoid NSAIDs (like ibuprofen) if you're dehydrated or experiencing vomiting Lifestyle considerations: Maintain regular sleep patterns to combat fatigue Gentle physical activity such as short walks may help with overall wellbeing, though avoid strenuous exercise if feeling unwell Keep a symptom diary to identify triggers and track improvement over time If symptoms remain troublesome despite these measures, discuss with your prescribing clinician whether a slower dose titration schedule might be appropriate

Weight loss effects of GLP-1RAs Liraglutide (3.0 mg, Saxenda), a GLP-1RA that activates the GLP-1 receptor, was approved by the FDA in December 2014 for adult obesity treatment [38] and has recently shown efficacy in adolescents aged 12 to 18 years

Cascella R, Evangelisti E, Zampagni M, Becatti M, D'Adamio G, Goti A, Liguri G, Fiorillo C, Cecchi C

Vitamin B12 deficiency is pretty common, and many people take B12 injections

Bremer J